SG11201507454XA - Influenza b virus reassortment - Google Patents
Influenza b virus reassortmentInfo
- Publication number
- SG11201507454XA SG11201507454XA SG11201507454XA SG11201507454XA SG11201507454XA SG 11201507454X A SG11201507454X A SG 11201507454XA SG 11201507454X A SG11201507454X A SG 11201507454XA SG 11201507454X A SG11201507454X A SG 11201507454XA SG 11201507454X A SG11201507454X A SG 11201507454XA
- Authority
- SG
- Singapore
- Prior art keywords
- influenza
- virus reassortment
- reassortment
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
- C12N2760/16252—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361779888P | 2013-03-13 | 2013-03-13 | |
| PCT/IB2014/059729 WO2014141125A2 (en) | 2013-03-13 | 2014-03-13 | Influenza virus reassortment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507454XA true SG11201507454XA (en) | 2015-10-29 |
Family
ID=50440715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507454XA SG11201507454XA (en) | 2013-03-13 | 2014-03-13 | Influenza b virus reassortment |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10232031B2 (en) |
| EP (1) | EP2968512A2 (en) |
| JP (1) | JP6525469B2 (en) |
| KR (1) | KR20150130344A (en) |
| CN (2) | CN105338999B (en) |
| AU (2) | AU2014229255B2 (en) |
| BR (1) | BR112015021880A2 (en) |
| CA (1) | CA2905612A1 (en) |
| HK (1) | HK1218511A1 (en) |
| IL (1) | IL240936B (en) |
| MX (1) | MX2015011529A (en) |
| SG (1) | SG11201507454XA (en) |
| WO (1) | WO2014141125A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011123495A1 (en) | 2010-03-30 | 2011-10-06 | Mount Sinai School Of Medicine | Influenza virus vaccines and uses thereof |
| EP4241785A3 (en) | 2011-09-20 | 2023-09-27 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
| ES2929942T3 (en) | 2012-12-18 | 2022-12-05 | Icahn School Med Mount Sinai | Influenza virus vaccines and their uses |
| US9908930B2 (en) | 2013-03-14 | 2018-03-06 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
| EP3247389A4 (en) | 2015-01-23 | 2019-10-30 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccination regimens |
| BR112017028011A2 (en) | 2015-06-26 | 2018-08-28 | Seqirus Uk Ltd | antigenically matched influenza vaccines |
| US10416171B2 (en) | 2015-07-07 | 2019-09-17 | Seqirus UK Limited | Influenza potency assays |
| MX2018015755A (en) | 2016-06-15 | 2019-08-29 | Icahn School Med Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof. |
| US11254733B2 (en) | 2017-04-07 | 2022-02-22 | Icahn School Of Medicine At Mount Sinai | Anti-influenza B virus neuraminidase antibodies and uses thereof |
| CN108018300B (en) | 2017-11-21 | 2020-08-28 | 浙江迪福润丝生物科技有限公司 | H7 subtype avian influenza vaccine strain for distinguishing immune animals and infected animals as well as preparation method and application thereof |
| WO2021173965A1 (en) * | 2020-02-28 | 2021-09-02 | Massachusetts Institute Of Technology | Identification of variable influenza residues and uses thereof |
| CN114262694B (en) * | 2021-12-06 | 2023-11-03 | 军事科学院军事医学研究院军事兽医研究所 | SARS-CoV-2 vaccine candidate strain using B type influenza virus as carrier and its construction method and application |
| CN116063409A (en) * | 2022-09-09 | 2023-05-05 | 中山大学·深圳 | Influenza B Mosaic recombinant protein, recombinant plasmid, construction method and application thereof |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| AU5543294A (en) | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
| DE19612966B4 (en) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK cells and methods of propagating influenza viruses |
| DE19612967A1 (en) | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Process for the propagation of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| TW570803B (en) | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| WO1999064571A1 (en) | 1998-06-12 | 1999-12-16 | Mount Sinai School Of Medicine Of The City University Of New York | Interferon inducing genetically engineered attenuated viruses |
| IT1307930B1 (en) * | 1999-01-26 | 2001-11-29 | Sinco Ricerche Spa | TRANSPARENT ARTICLES IN POLYESTER RESIN (MG32). |
| BR0014281A (en) | 1999-09-24 | 2002-05-21 | Smithkline Beecham Biolog | Vaccine against intranasal flu virus |
| WO2001064846A1 (en) | 2000-03-03 | 2001-09-07 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| AU2002221624A1 (en) | 2000-09-25 | 2002-04-02 | Bayer Aktiengesellschaft | Human e3 ubiquitin protein ligase-like enzyme |
| AU2356002A (en) | 2000-09-25 | 2002-04-02 | Polymun Scient Immunbio Forsch | Live vaccine and method of manufacture |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| JP5208347B2 (en) | 2001-02-23 | 2013-06-12 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | New vaccine |
| JP2004536785A (en) | 2001-02-23 | 2004-12-09 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | New vaccine |
| MY134424A (en) | 2001-05-30 | 2007-12-31 | Saechsisches Serumwerk | Stable influenza virus preparations with low or no amount of thiomersal |
| KR20070008625A (en) | 2004-04-05 | 2007-01-17 | 화이자 프로덕츠 인코포레이티드 | Microfluidized oil-in-water emulsions and vaccine compositions |
| WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| CA2566858A1 (en) | 2004-05-20 | 2005-12-01 | Id Biomedical Corporation | Process for the production of an influenza vaccine |
| HUE025727T2 (en) * | 2004-05-24 | 2016-04-28 | Medimmune Llc | Multi plasmid system for the production of influenza virus |
| CA2592120A1 (en) | 2004-12-23 | 2006-07-06 | Medimmune Vaccines, Inc. | Non-tumorigenic mdck cell line for propagating viruses |
| EP2441471B1 (en) * | 2005-03-08 | 2014-10-08 | MedImmune, LLC | Reassortant influenza viruses |
| FR2884255B1 (en) | 2005-04-11 | 2010-11-05 | Vivalis | USE OF EBX AVIATION STEM CELL LINES FOR THE PRODUCTION OF INFLUENZA VACCINE |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| AU2006262381A1 (en) | 2005-06-21 | 2007-01-04 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
| US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
| ATE494906T1 (en) | 2005-11-01 | 2011-01-15 | Novartis Vaccines & Diagnostic | CELL-DERIVED VIRAL VACCINES WITH LOW AMOUNTS OF RESIDUAL CELL DNA |
| NZ568210A (en) | 2005-11-04 | 2012-12-21 | Novartis Vaccines & Diagnostic | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
| EP2377551A3 (en) | 2005-11-04 | 2013-04-24 | Novartis Vaccines and Diagnostics S.r.l. | Adjuvanted influenza vaccines including cytokine-inducing agents |
| FR2896162B1 (en) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | EMULSION OIL IN THERMOREVERSIBLE WATER |
| CN1810961B (en) * | 2006-02-22 | 2010-05-12 | 中国人民解放军军事医学科学院微生物流行病研究所 | Recombinant influenza virus and its preparation and application |
| EP2010557B1 (en) * | 2006-03-31 | 2014-02-26 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
| CA2646526C (en) | 2006-04-19 | 2016-01-12 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral rna in canine cells |
| BRPI0717219B8 (en) | 2006-10-12 | 2021-05-25 | Glaxosmithkline Biologicals Sa | immunogenic composition, and, use of an immunogenic composition |
| EA200900784A1 (en) | 2006-12-06 | 2009-12-30 | Новартис Аг | VACCINES INCLUDING ANTIGENS FROM FOUR STRAINS OF THE INFLUENZA VIRUS |
| EP2045323A1 (en) | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| CN102149405A (en) * | 2008-07-11 | 2011-08-10 | 米迪缪尼股份有限公司 | Influenza hemagglutinin and neuraminidase variants |
| CN102257135B (en) | 2008-12-16 | 2017-06-09 | 纳米医疗公司 | The production of influenza vaccines |
| EP2573184A1 (en) | 2009-05-21 | 2013-03-27 | Novartis AG | Reverse genetics using non-endogenous POL I promoters |
| JP2013500712A (en) | 2009-07-31 | 2013-01-10 | ノバルティス アーゲー | Reverse genetics |
| AU2010309404B2 (en) | 2009-10-20 | 2015-07-09 | Seqirus UK Limited | Improved reverse genetics methods for virus rescue |
| AU2011254204B2 (en) | 2010-05-21 | 2015-08-20 | Seqirus UK Limited | Influenza virus reassortment method |
-
2014
- 2014-03-13 CN CN201480027225.4A patent/CN105338999B/en active Active
- 2014-03-13 MX MX2015011529A patent/MX2015011529A/en active IP Right Grant
- 2014-03-13 CA CA2905612A patent/CA2905612A1/en not_active Abandoned
- 2014-03-13 WO PCT/IB2014/059729 patent/WO2014141125A2/en active Application Filing
- 2014-03-13 JP JP2015562504A patent/JP6525469B2/en active Active
- 2014-03-13 SG SG11201507454XA patent/SG11201507454XA/en unknown
- 2014-03-13 US US14/775,066 patent/US10232031B2/en active Active
- 2014-03-13 AU AU2014229255A patent/AU2014229255B2/en active Active
- 2014-03-13 CN CN202010070674.4A patent/CN111334530A/en active Pending
- 2014-03-13 KR KR1020157027045A patent/KR20150130344A/en not_active Application Discontinuation
- 2014-03-13 BR BR112015021880A patent/BR112015021880A2/en not_active IP Right Cessation
- 2014-03-13 EP EP14715683.0A patent/EP2968512A2/en not_active Withdrawn
-
2015
- 2015-08-31 IL IL24093615A patent/IL240936B/en active IP Right Grant
-
2016
- 2016-06-07 HK HK16106531.5A patent/HK1218511A1/en unknown
-
2019
- 2019-03-13 AU AU2019201704A patent/AU2019201704A1/en not_active Abandoned
- 2019-10-18 US US16/657,082 patent/US10864264B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN105338999A (en) | 2016-02-17 |
| KR20150130344A (en) | 2015-11-23 |
| AU2019201704A1 (en) | 2019-04-04 |
| CA2905612A1 (en) | 2014-09-18 |
| IL240936A0 (en) | 2015-11-30 |
| US10232031B2 (en) | 2019-03-19 |
| IL240936B (en) | 2019-11-28 |
| MX2015011529A (en) | 2016-02-05 |
| JP6525469B2 (en) | 2019-06-05 |
| US20200215184A1 (en) | 2020-07-09 |
| EP2968512A2 (en) | 2016-01-20 |
| CN111334530A (en) | 2020-06-26 |
| US20160038585A1 (en) | 2016-02-11 |
| WO2014141125A3 (en) | 2014-12-04 |
| BR112015021880A2 (en) | 2017-09-26 |
| AU2014229255A1 (en) | 2015-09-24 |
| US10864264B2 (en) | 2020-12-15 |
| JP2016509864A (en) | 2016-04-04 |
| AU2014229255B2 (en) | 2018-12-13 |
| HK1218511A1 (en) | 2017-02-24 |
| WO2014141125A2 (en) | 2014-09-18 |
| CN105338999B (en) | 2020-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222882A1 (en) | Influenza virus reassortment | |
| IL276210A (en) | Mers-cov vaccine | |
| HK1218511A1 (en) | Influenza b virus reassortment | |
| IL241881B (en) | Composition comprising at least two influenza a virus-neutralizing-binding molecules | |
| HK1223110A1 (en) | Influenza virus vaccines and uses thereof | |
| HK1220163A1 (en) | Sprayer | |
| ZA201508642B (en) | Malaria vaccine | |
| HK1218872A1 (en) | Hepatitis b vaccine | |
| GB201310432D0 (en) | Virus Production | |
| EP3063273B8 (en) | Influenza virus vector for virotherapy | |
| GB201313201D0 (en) | Virus Detection | |
| HK1217638A1 (en) | Influenza virus reassortment | |
| HK1217206A1 (en) | Vaccine | |
| HK1223643A1 (en) | Semi-live respiratory syncytial virus vaccine | |
| GB201301119D0 (en) | Viral vaccines | |
| IL227462A0 (en) | Sprayer | |
| HK1219904A1 (en) | Novel vaccines against multiple subtypes of dengue virus | |
| GB201304827D0 (en) | Infulenza virus reassortment | |
| GB201314063D0 (en) | Virus | |
| GB201306812D0 (en) | Virus | |
| AU2013905065A0 (en) | Viral vaccine | |
| AU2013905043A0 (en) | Viral vaccine | |
| AU2013904384A0 (en) | Viral vaccine | |
| FR3005265B3 (en) | REASSORTING THE INFLUENZA VIRUS | |
| GB201320646D0 (en) | Vaccine |